acetazolamide


Also found in: Dictionary, Thesaurus, Medical, Acronyms, Wikipedia.

acetazolamide

[‚as·ə·tə′zäl·ə‚mīd]
(pharmacology)
(CH3CONH)C2N2S(SO2NH2) An odorless, white to faintly yellowish-white, crystalline powder with a melting point of 258°C; slightly soluble in water; used as a diuretic.
Mentioned in ?
References in periodicals archive ?
The report on acetazolamide market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global acetazolamide market over the period of 2017 to 2025.
We regret, therefore, if the brevity of our article and its strong emphasis on safe acclimatisation practices and basic field management of altitude illness have left the misapprehension that we do not advocate the use of acetazolamide where indicated.
The most common mode of therapy was topical, i.e., as eye drops, the only oral drug prescribed was acetazolamide; this result is similar to other studies reported from India.
Akyurekli, "Treatment of idiopathic intracranial hypertension: topiramate vs acetazolamide, an open-label study," Acta Neurologica Scandinavica, vol.
Maignan et al., "Acetazolamide for Monge's disease: efficiency and tolerance of 6-month treatment," American Journal of Respiratory and Critical Care Medicine, vol.
Childhood pseudotumor cerebri: Clinical and intracranial pressure response to acetazolamide and fiirosemide treatment in a case series.
The patient reported that she was taking acetazolamide for IIH treatment orally during the last 15 days with an onset dosage of 750 mg/day, increased to 1500 mg/day after the 7th day of usage.
In order to prevent restenosis the patient's administration with acetazolamide was maintained as presumably elevation of CSF pressure would have led to restenosis.
Usually it is recommended to use 500 mg/ day of acetazolamide. Because of the side effects such as paresthesias or mild diuresis management a smaller dose 250 mg/day can be effective as well [4,6,8-10].
General linear model with repeated measures analysis of variance for neurological scores at 5 repeated measures showed that Rg1-treated group (1.00 [+ or -] 0.08), acetazolamide-treated group (1.03 [+ or -] 0.08) and Rg1 plus acetazolamide group (0.70 [+ or -] 0.08) could significantly reduce the changing trend of neurological deficit scores when Compared with the MCAO model group (1.55 [+ or -] 0.08) (p < 0.05), and Rg1 plus acetazolamide treatment could further reduce the changing trend of neurological deficit scores when compared with the Rg1 and acetazolamide treatment, respectively (p < 0.05) (Fig.
Acetazolamide, [C.sub.4][H.sub.6][N.sub.4][O.sub.3][S.sub.2] (1,3,4-thiadiazole-2-sulfonamide,5-acetamido), is a sulfonamide derivative and carbonic anhydrase inhibitor used clinically to lower intraocular pressure in glaucomatous patients.
M2 EQUITYBITES-November 14, 2012-Sagent Pharmaceuticals Inc introduces Acetazolamide for Injection USP for treating edema(C)2012 M2 COMMUNICATIONS http://www.m2.com